The Real Reason Why The Vaccine Rollout is So Slow
Listen to story:
Download: mp3 (Duration: 23:32 — 21.5MB)
FEATURING DEAN BAKER – The United States has currently vaccinated just over 25 million people, out of 325 million, against the COVID-19 virus. Vaccines, which were sold as a panacea by the previous administration, have not been produced and distributed as fast as people had hoped. Although the timeframe of development, testing, and approval was lightning fast, now, various reasons have slowed down the deployment of the shots in a country that in previous years was been able to dispense 2 million flu shots a day. Why is the rollout of vaccines so slow?
Read Dean Baker’s article ‘Waiting for a Vaccine: Killing for Inequality,’ HERE.
Dean Baker, senior economist at the Center for Economic and Policy Research, which he also co-founded. He is the author of several books, including Rigged: How Globalization and the Rules of the Modern Economy Were Structured to Make the Rich Richer. His blog, “Beat the Press,” provides commentary on economic reporting. His analyses have appeared in many major publications, including the Atlantic Monthly, the Washington Post, the London Financial Times, and the New York Daily News.